1Cipriani, A, Furukawa, TA, Salanti, G, Chaimani, A, Atkinson, LZ, Ogawa, Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018; 391: 1357–66.
2Correll, CU, Detraux, J, De Lepeleire, J, De Hert, M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015; 14: 119–36.
3Miura, T, Noma, H, Furukawa, TA, Mitsuyasu, H, Tanaka, S, Stockton, S, et al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. Lancet Psychiatry 2014; 1: 351–9.
4Correll, CU, Rubio, JM, Kane, JM. What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? World Psychiatry 2018; 17: 149–60.
5Schultze-Lutter, F, Michel, C, Schmidt, SJ, Schimmelmann, BG, Maric, NP, Salokangas, RKR, et al. EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry 2015; 30: 405–16.
6Zwicker, A, Denovan-Wright, EM, Uher, R. Gene–environment interplay in the etiology of psychosis. Psychol Med 2018; 48: 1925–36.
7Uher, R, Zwicker, A. Etiology in psychiatry: embracing the reality of poly-gene-environmental causation of mental illness. World Psychiatry 2017; 16: 121–9.
8Gandal, MJ, Haney, JR, Parikshak, NN, Leppa, V, Ramaswami, G, Hartl, C, et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 2018; 359: 693–7.
9Cross Disorder Group of the Psychiatric Genomics Consortium. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013; 45: 984–94.
10Caspi, A, Houts, RM, Belsky, DW, Goldman-Mellor, SJ, Harrington, H, Israel, S, et al. The p factor: one general psychopathology factor in the structure of psychiatric disorders? Clin Psychol Sci 2014; 2: 119–37.
11Schultze-Lutter, F, Theodoridou, A. The concept of basic symptoms: its scientific and clinical relevance. World Psychiatry 2017; 16: 104–5.
12Schultze-Lutter, F, Ruhrmann, S, Fusar-Poli, P, Bechdolf, A, Klosterkötter, J. Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des 2012; 18: 351–7.
13Schultze-Lutter, F. Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophr Bull. 2009; 35: 5–8.
14Fux, L, Walger, P, Schimmelmann, BG, Schultze-Lutter, F. The Schizophrenia Proneness Instrument, Child and Youth version (SPI-CY): practicability and discriminative validity. Schizophr Res 2013; 146: 69–78.
15Michel, C, Ruhrmann, S, Schimmelmann, BG, Klosterkötter, J, Schultze-Lutter, F. Course of clinical high-risk states for psychosis beyond conversion. Eur Arch Psychiatry Clin Neurosci 2018; 268: 39–48.
16Schultze-Lutter, F, Michel, C, Ruhrmann, S, Schimmelmann, BG. Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult community. Psychol Med 2018; 48: 1167–78.
17Lo Cascio, N, Saba, R, Hauser, M, Lammers Vernal, D, Al-Jadiri, A, Borenstein, Y, et al. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis. Eur Child Adolesc Psychiatry 2016; 25: 1091–102.
18Gottesman, II, Laursen, TM, Bertelsen, A, Mortensen, PB. Severe mental disorders in offspring with 2 psychiatrically ill parents. Arch Gen Psychiatry 2010; 67: 252.
19Rasic, D, Hajek, T, Alda, M, Uher, R. Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies. Schizophr Bull 2014; 40: 28–38.
20Forstner, AJ, Hecker, J, Hofmann, A, Maaser, A, Reinbold, CS, Muhleisen, TW, et al. Identification of shared risk loci and pathways for bipolar disorder and schizophrenia. PLoS One 2017; 12: e0171595.
21Selzam, S, Coleman, JRI, Moffitt, TE, Caspi, A, Plomin, R. A polygenic p factor for major psychiatric disorders. Transl Psychiatry 2018; 8: 205.
22Meng, H, Graf Schimmelmann, B, Koch, E, Bailey, B, Parzer, P, Gunter, M, et al. Basic symptoms in the general population and in psychotic and non-psychotic psychiatric adolescents. Schizophr Res 2009; 111: 32–8.
23Klosterkötter, J, Gross, G, Huber, G, Wieneke, A, Steinmeyer, EM, Schultze-Lutter, F. Evaluation of the ‘Bonn Scale for the Assessment of Basic Symptoms - BSABS’ as an instrument for the assessment of schizophrenia proneness: a review of recent findings. Neurol Psychiatry Brain Res 1997; 5: 137–50.
24Uher, R, Cumby, J, MacKenzie, LE, Morash-Conway, J, Glover, JM, Aylott, A, et al. A familial risk enriched cohort as a platform for testing early interventions to prevent severe mental illness. BMC Psychiatry 2014; 14: 344.
25Endicott, J. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35: 837.
26First, MB. Structured Clinical Interview for the DSM (SCID). In The Encyclopedia of Clinical Psychology (eds Cautin, RL and Lilienfeld, SO): 1–6. John Wiley & Sons, 2015.
27Kaufman, J, Birmaher, B, Brent, D, Rao, U, Flynn, C, Moreci, P, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36: 980–8.
28Schimmelmann, BG, Michel, C, Martz-Irngartinger, A, Linder, C, Schultze-Lutter, F. Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: findings from the BEAR and BEARS-kid studies. World Psychiatry 2015; 14: 189–97.
29Bates, D, Mächler, M, Bolker, B, Walker, S. Fitting linear mixed-effects models using lme4. J Stat Softw 2015; 67: 1–48.
30R Core Team. R: A Language and Environment for Statistical Computing. R Foundation, 2008.
31Schultze-Lutter, F, Ruhrmann, S, Michel, C, Kindler, J, Schimmelmann, BG, Schmidt, SJ. Age effects on basic symptoms in the community: a route to gain new insight into the neurodevelopment of psychosis? Eur Arch Psychiatry Clin Neurosci 2018; Oct 25 (Epub ahead of print).
32Klosterkötter, J, Hellmich, M. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158–64.
33van Os, J, Reininghaus, U. Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry 2016; 15: 118–24.
34van Os, J, Guloksuz, S. A critique of the ‘ultra-high risk’ and ‘transition’ paradigm. World Psychiatry 2017; 16: 200–6.
35Perlis, RH, Uher, R, Ostacher, M, Goldberg, JF, Trivedi, MH, Rush, J, et al. Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. Arch Gen Psychiatry 2010; 68: 351.
36Kelleher, I, Keeley, H, Corcoran, P, Lynch, C, Fitzpatrick, N, Devlin, C, et al. Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies. Br J Psychiatry 2012; 201: 26–32.
37Wigman, JTW, van Nierop, M, Vollebergh, WAM, Lieb, R, Beesdo-Baum, K, Wittchen, H, et al. Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity–Implications for diagnosis and ultra-high risk research. Schizophr Bull 2012; 38: 247–57.
38Wigman, JTW, van Os, J, Abidi, L, Huibers, MJH, Roelofs, J, Arntz, A. Subclinical psychotic experiences and bipolar spectrum features in depression: association with outcome of psychotherapy. Psychol Med 2014; 44: 325–36.
39Power, RA, Kyaga, S, Uher, R, MacCabe, JH, Langstrom, N, Landen, M, et al. Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. JAMA Psychiatry 2013; 70: 22.
40Heckman, JJ. The developmental origins of health. Health Econ 2012; 21: 24–9.
41Bayer, JK, Rapee, RM, Hiscock, H, Ukoumunne, OC, Mihalopoulos, C, Wake, M. Translational research to prevent internalizing problems early in childhood. Depress Anxiety 2011; 28: 50–7.